29 Apr 2021

Neurosoft Bioelectronics selected for the Medlim Fast Track Acceleration Program

We are very pleased to announce that Neurosoft Bioelectronics has been selected to participate in the Medlim Fast Track Acceleration Program.

This year the program has selected 9 promising startups developing breakthrough technology in the Cardiovascular, Diabetes, Neurological & Orthopedic fields. Each startup will receive support in bringing their medical devices to the market through workshops, interaction with experts, coaching sessions and a final pitch event with investors.

About Medlim

The Medlim program was initiated by Medtronic and LIOF, together with the Brightlands Maastricht University, Medace, and imec.istart centers. These world-class partners provide expertise in the domains of business, medical device development, regulatory, IP and financing.

Learn more about the program on the Medlim website.

Neurosoft Bioelectronics adds experts in Neuromodulation & Tinnitus to its Advisory Board